"An estimated half a million epinephrine autoinjectors are coming off the market. The US Food and Drug Administration (FDA) is advising patients to call their doctor for an alternative, but some say there won't be enough supply to meet the demand."...
To prevent contaminating the dropper tip and solution, care should be taken not to touch any surface, the eyelids, or surrounding areas with the dropper tip of the bottle or single-use container. Keep bottle tightly closed when not in use. Discard single-use container immediately after use. This product is sterile when packaged.
Patients should be advised not to wear a contact lens if their eye is red. OPTIVAR (azelastine hydrochloride) ® should not be used to treat contact lens related irritation. The preservative in OPTIVAR (azelastine hydrochloride) ® , benzalkonium chloride, may be absorbed by soft contact lenses. Patients who wear soft contact lenses and whose eyes are not red, should be instructed to wait at least ten minutes after instilling OPTIVAR (azelastine hydrochloride) ® before they insert their contact lenses.
Last reviewed on RxList: 8/5/2008
This monograph has been modified to include the generic and brand name in many instances.
Additional Optivar Information
Optivar - User Reviews
Optivar User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Allergies & Asthma
Improve treatments & prevent attacks.